Breaking News, Promotions & Moves

Repligen Names Olivier Loeillot President, Chief Commercial Officer

Loeillot will oversee all business units as well as the commercial organization.

Repligen Corporation, a life sciences company focused on bioprocessing technology, appointed Olivier Loeillot to the newly created position of president and chief commercial officer (CCO). Loeillot served a combined 12 years with Cytiva and GE Healthcare Life Sciences. In his most recent role at Cytiva, he served as bioprocess president from 2018 to 2022, overseeing the overall Bioprocess portfolio from cell culture media to purification resins and including process equipment, single-use tech...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters